Current projections of the global menopause supplement market indicate a valuation of US$ 934.8 million by 2024. Looking ahead to 2034, the forecast projects a CAGR of 5.7%. The estimated valuation of US$ 1,429.2 million in 2034 comes from the growing demand for natural and herbal supplements.
| Attributes | Key Insights |
|---|---|
| Menopause Supplement Market Size (2024E) | US$ 934.8 million |
| Menopause Supplement Market Value (2034F) | US$ 1,429.2 million |
| Value-based CAGR (2024 to 2034) | 5.7% |
An increasing number of women entering menopause worldwide, coupled with a high prevalence of menopausal symptoms, is propelling the demand for these supplements. Increasing awareness of menopause and the desire for alternative treatments to traditional hormone replacement therapy are projected to fuel the market.
Leading manufacturers are investing and shifting toward personalized approaches to supplements, formulating supplements made for the specific needs and preferences of menopausal women. This includes evidence-based formulations using clinically proven ingredients and exploring new delivery formats to address a wide range of menopause symptoms.
Companies in the United States, such as NOW Foods and Herbalife Nutrition, are effectively marketing and branding menopause nutrition to capture the attention of menopausal consumers. Manufacturers and healthcare professionals are promoting awareness & acceptance of menopause through open discussions and reduced stigma, aiming to meet the growing demand for solutions.
Consumers are seeking plant-based, herbal, and non-GMO supplements for symptom relief, including sleep disturbances and mood change. High stress, poor diet, and environmental toxins in modern lifestyles are set to worsen menopausal symptoms, leading several women to use supplements as part of a holistic health management strategy.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Global menopause supplement sales grew at a CAGR of 4.5% from 2019 to 2023. Menopause, once considered a natural part of aging, has led to increased demand for supportive treatments, including supplements.
Between 2019 and 2023, hormone replacement therapy (HRT) was widely prescribed to alleviate menopausal symptoms. However, concerns about its safety, particularly the increased risk of cardiovascular disease and breast cancer, shifted consumer preferences toward alternative treatments like dietary supplements.
Concerns about synthetic hormones led to increased interest in natural and herbal supplements for managing menopausal symptoms. Ingredients such as black cohosh, soy isoflavones, red clover, and dong quai gained popularity due to their perceived efficacy and lower risk of adverse effects. Scientific research and clinical trials have validated the benefits of these supplements, providing consumers with more evidence-based options for managing menopause symptoms.
By 2034, the market is predicted to rise at 5.7% CAGR. The acceptance & awareness of menopause, rising demand for natural & holistic approaches to health, and development in product formulations are fueling the market. Growing market reach, supported by increasing disposable income and middle class, is projected to help new entrants in market expansion and penetration.
Digital health platforms, personalized nutrition solutions, and telephonic health services are projected to increase the utilization of supplements worldwide. Menopause supplement manufacturers are prioritizing raw material transparency, with standard regulatory frameworks to govern growth in the menopause supplement product market.
Rising demand for natural & herbal supplements and shift toward personalized approaches are set to fuel the market. The market is influenced by the shift toward online shopping and e-commerce platforms, propelled by consumer preference for convenience and growth in retail channels. Growing focus on bone health, need to reduce the risk of osteoporosis, and increasing consumer focus on sustainability & ethical sourcing are also anticipated to fuel the market.
Emerging trend of incorporating menopause-supporting ingredients into functional food and beverage products is set to surge demand for menopause supplement. Increasing demand for these supplements backed by scientific research and clinical evidence is also projected to gain traction in the market.
Principal Consultant
The section below displays the predicted supplement revenue in leading countries. The United States and China will remain the top consumers, generating revenues worth US$ 290.1 million and US$ 185.8 million, respectively, in 2034.
| Countries | Market Value (2034) |
|---|---|
| United States | US$ 290.1 million |
| Germany | US$ 114.3 million |
| Japan | US$ 85.8 million |
| China | US$ 185.8 million |
| South Korea | US$ 100.0 million |
The table below showcases the CAGRs of several countries present in the global market. Analysis of these countries would enable potential clients to find the ideal investment area and gain a competitive edge. China and South Korea are set to remain at the forefront of the market by witnessing CAGRs of 7.8% and 8.0%, respectively, from 2024 to 2034.
| Countries | CAGR (2024 to 2034) |
|---|---|
| United States | 5.1% |
| Germany | 5.9% |
| Japan | 6.8% |
| China | 7.8% |
| South Korea | 8.0% |
The United States menopause supplement industry is poised to exhibit a CAGR of 5.1% during the forecast period. By 2034, the country is projected to reach US$ 290.1 million. The market is growing due to increasing demand from health-conscious consumers seeking natural and herbal supplements to support their well-being during menopause.
Established players dominate the market due to their strong distribution networks and marketing strategies in the United States. The United States menopause supplement market is regulated by the FDA. It requires manufacturers to adhere to labeling, safety, and quality assurance guidelines.
Menopause supplement demand in Germany is anticipated to rise at a steady CAGR of 5.9% during the forecast period. By 2034, the country is set to hold a market share of 17.9% in Europe. Consumers' increased knowledge and preference for evidence-based menopause supplements are fueling growth opportunities for established players in Germany.
Japan’s menopause supplement market is poised to exhibit a CAGR of 6.8% during the assessment period. By 2034, the market size is set to reach US$ 85.8 million. Japan is known for its robust health and wellness culture, emphasizing preventive healthcare and natural remedies.
Japan has a significant elderly population, with several women entering or experiencing menopause or menopausal symptoms, fueling the market. Healthcare professionals and public health campaigns play a key role in spreading information and providing guidance to women experiencing menopause. It includes recommendations for dietary supplements to manage symptoms and support hormonal balance.
Growing aging population in South Korea is fueling a surge in women entering menopause, leading to increased demand for menopause supplements. Increased awareness about menopause and its symptoms is prompting more women to seek information and solutions, including dietary supplements.
Consumers in South Korea are increasingly seeking natural and herbal supplements to manage menopause symptoms, with ingredients like black cohosh and red clover gaining popularity. South Korea is projected to surge at a CAGR of 8.0% through 2034.
Menopause supplements are gaining popularity for their benefits on bone and heart health among consumers in China. E-commerce channels are playing a significant role in distributing these supplements in the country, as consumers prefer the convenience of purchasing online and easy comparison of options.
China is projected to reach US$ 185.8 million, growing at a CAGR of 7.8% by 2034. Leading companies in the country use social media, influencer marketing, and educational campaigns to reach their target audience, with celebrities and healthcare professionals promoting menopause nutrition and raising awareness.
The table below showcases the top segments and their shares in the market. Based on form, the capsule segment is projected to generate a share of 36.4% in 2024. By sale channel, online pharmacies are anticipated to hold a share of 16.8% in 2024.
| Segment | Market Share (2024) |
|---|---|
| Capsules (Form) | 36.4% |
| Online Pharmacies (Sale Channels) | 16.8% |
The capsules segment is set to register a CAGR of 4.4% from 2024 to 2034. The target segment is estimated to reach US$ 351.4 million by 2024. Capsules are easy to consume, making them a convenient option for menopausal women who prefer a simple and hassle-free way to incorporate supplements into their daily routine.
Capsules are often used to encapsulate ingredients with strong tastes or odors, such as herbs and botanicals commonly found in menopause supplements. These help in precise dosage control, as the amount of active ingredients in each capsule can be accurately measured and standardized. Capsules are gaining traction in the market due to their longer shelf life than other dosage forms, such as liquids or powders, reducing the risk of spoilage or degradation over time.
The online pharmacies segment is anticipated to thrive at an 8.6% CAGR during the projection period. Online pharmacies offer convenience and accessibility to consumers, allowing them to browse and purchase a wide range of menopause products & supplements from their comfort. Women can easily compare products, read reviews, and choose supplements that suit their needs and preferences, surging demand for menopause supplements online.
Convenient delivery options, including home delivery and express shipping, make it easy for consumers to receive their supplements on time. Several women find purchasing supplements discreetly online more comfortable than in person at a physical store due to the sensitive topic it raises. These are the factors fueling sales of supplements through online pharmacies.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The menopause supplement industry has a diverse and dynamic competitive landscape. Leading companies specializing in diverse fields focus on research & development, sustainable sourcing, and new formulations.
Key companies emphasize environmentally friendly practices, product certifications, and satisfying the increased demand for natural & sustainable ingredients. Leading manufacturers and companies preserve their market position and capitalize on the growing demand by focusing on quality, innovation, and matching customer preferences. Several companies are trying to innovate new ingredients and formulations, such as vitamin K, collagen, and omega-3, to use in menopause supplements.
For instance
The market is set to reach US$ 934.8 million in 2024.
Demand for menopause supplements is slated to surge at a 5.7% CAGR through 2034.
The market is set to reach US$ 1,429.2 million in 2034.
Nature's Bounty Co., NOW Foods, and Pfizer Inc. are the key players.
Capsule segment is estimated to hold a significant market share in 2024.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Technology Roadmap
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition
3. Market Dynamics
3.1. Drivers
3.1.1. Supply Side Drivers
3.1.2. Demand Side drivers
3.1.3. Economic Side Drivers
3.2. Restraints
3.3. Opportunity
3.4. Market trends By Region
3.5. Forecast Factors - Relevance & Impact
3.6. Key Regulations and Policies
4. Value Chain Analysis
4.1. Operating margins at each node of the supply chain
4.2. List of Active Market Participants
5. Global Market- Pricing Analysis
5.1. Price Point Assessment by Region
5.1.1. Manufacturer-Level Pricing
5.1.2. Distributor Level Pricing
5.2. Price Point Assessment By Product
5.3. Price Forecast till 2034
6. Global Market Size in Value (US$ million) and Volume Analysis 2019 to 2023 and Forecast, 2024 to 2034
6.1. Historical Market Size in Value (US$ million) and Volume (MT) Analysis, 2019 to 2023
6.2. Current and Future Market Size in Value (US$ million) and Volume (MT) Analysis, 2024 to 2034
6.2.1. Y-o-Y Growth Trend Analysis
6.2.2. Absolute $ Opportunity Analysis
7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product Type
7.1. Introduction / Key Findings
7.2. Historical Market Size in Value (US$ million) and Volume Analysis By Product Type, 2019 to 2023
7.3. Current and Future Market Size in Value (US$ million) and Volume Analysis and Forecast By Product Type, 2024 to 2034
7.3.1. Hormonal Supplements
7.3.2. Non-hormonal Supplements
7.3.3. Nutritional Supplements
7.3.4. Other
7.4. Market Attractive Analysis By Product Type
8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Form
8.1. Introduction / Key Findings
8.2. Historical Market Size in Value (US$ million) and Volume Analysis By Form, 2019 to 2023
8.3. Current and Future Market Size in Value (US$ million) and Volume Analysis and Forecast By Form, 2024 to 2034
8.3.1. Tablets
8.3.2. Capsules
8.3.3. Liquids
8.3.4. Powders
8.3.5. Gummies
8.3.6. Soft Gels
8.4. Market Attractiveness Analysis By Form
9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Sales Channel
9.1. Introduction / Key Findings
9.2. Historical Market Size in Value (US$ million) and Volume Analysis By Sales Channel, 2019 to 2023
9.3. Current and Future Market Size in Value (US$ million) and Volume Analysis and Forecast By Sales Channel, 2024 to 2034
9.3.1. Store-based
9.3.1.1. Modern Trade
9.3.1.2. Hospital Pharmacies
9.3.1.3. Retail Pharmacies
9.3.1.4. Drug Stores
9.3.2. Online Pharmacies
9.4. Market Attractiveness Analysis By Sales Channel
10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Region
10.1. Introduction
10.2. Historical Market Size in Value (US$ million) and Volume Analysis By Region, 2019 to 2023
10.3. Current Market Size in Value (US$ million) and Volume Analysis and Forecast By Region, 2024 to 2034
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. East Asia
10.3.5. South Asia
10.3.6. Oceania
10.3.7. Middle East & Africa
10.4. Market Attractiveness Analysis By Region
11. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034
11.1. Introduction
11.2. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2019 to 2023
11.3. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2024 to 2034
11.3.1. By Country
11.3.1.1. United States
11.3.1.2. Canada
11.3.2. By Product Type
11.3.3. By Form
11.3.4. By Sales Channel
11.4. Market Attractiveness Analysis
11.4.1. By Country
11.4.2. By Product Type
11.4.3. By Form
11.4.4. By Sales Channel
11.5. Key Takeaways
12. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034
12.1. Introduction
12.2. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2019 to 2023
12.3. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2024 to 2034
12.3.1. By Country
12.3.1.1. Brazil
12.3.1.2. Mexico
12.3.1.3. Argentina
12.3.1.4. Rest of Latin America
12.3.2. By Product Type
12.3.3. By Form
12.3.4. By Sales Channel
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. Product Type
12.4.3. By Form
12.4.4. By Sales Channel
12.5. Key Takeaways
13. Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034
13.1. Introduction
13.2. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2019 to 2023
13.3. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2024 to 2034
13.3.1. By Country
13.3.1.1. Germany
13.3.1.2. United kingdom
13.3.1.3. France
13.3.1.4. Italy
13.3.1.5. Spain
13.3.1.6. BENELUX
13.3.1.7. Nordic
13.3.1.8. Russia
13.3.1.9. Poland
13.3.1.10. Rest of Europe
13.3.2. By Product Type
13.3.3. By Form
13.3.4. By Sales Channel
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Product Type
13.4.3. By Form
13.4.4. By Sales Channel
13.5. Key Takeaways
14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034
14.1. Introduction
14.2. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2019 to 2023
14.3. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2024 to 2034
14.3.1. By Country
14.3.1.1. China
14.3.1.2. Japan
14.3.1.3. South Korea
14.3.2. By Product Type
14.3.3. By Form
14.3.4. By Sales Channel
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product Type
14.4.3. By Form
14.4.4. By Sales Channel
14.5. Key Takeaways
15. South Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034
15.1. Introduction
15.2. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2019 to 2023
15.3. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2024 to 2034
15.3.1. By Country
15.3.1.1. India
15.3.1.2. Thailand
15.3.1.3. Malaysia
15.3.1.4. Indonesia
15.3.1.5. Singapore
15.3.1.6. Vietnam
15.3.1.7. Philippines
15.3.1.8. Rest of South Asia
15.3.2. By Product Type
15.3.3. By Form
15.3.4. By Sales Channel
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product Type
15.4.3. By Form
15.4.4. By Sales Channel
15.5. Key Takeaways
16. Oceania Market Analysis 2019 to 2023 and Forecast 2024 to 2034
16.1. Introduction
16.2. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2019 to 2023
16.3. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2024 to 2034
16.3.1. By Country
16.3.1.1. Australia
16.3.1.2. New Zealand
16.3.2. By Product Type
16.3.3. By Form
16.3.4. By Sales Channel
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product Type
16.4.3. By Form
16.4.4. By Sales Channel
16.5. Key Takeaways
17. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034
17.1. Introduction
17.2. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2019 to 2023
17.3. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2024 to 2034
17.3.1. By Country
17.3.1.1. GCC Countries
17.3.1.2. Turkiye
17.3.1.3. Egypt
17.3.1.4. South Africa
17.3.1.5. Rest of Middle East and Africa
17.3.2. By Product Type
17.3.3. By Form
17.3.4. By Sales Channel
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product Type
17.4.3. By Form
17.4.4. By Sales Channel
17.5. Key Takeaways
18. Country-level Market Analysis, 2024
18.1. United States Market Analysis
18.1.1. By Product Type
18.1.2. By Form
18.1.3. By Sales Channel
18.2. Canada Market Analysis
18.2.1. By Product Type
18.2.2. By Form
18.2.3. By Sales Channel
18.3. Brazil Market Analysis
18.3.1. By Product Type
18.3.2. By Form
18.3.3. By Sales Channel
18.4. Mexico Market Analysis
18.4.1. By Product Type
18.4.2. By Form
18.4.3. By Sales Channel
18.5. Argentina Market Analysis
18.5.1. By Product Type
18.5.2. By Form
18.5.3. By Sales Channel
18.6. Germany Market Analysis
18.6.1. By Product Type
18.6.2. By Form
18.6.3. By Sales Channel
18.7. United Kingdom Market Analysis
18.7.1. By Product Type
18.7.2. By Form
18.7.3. By Sales Channel
18.8. France Market Analysis
18.8.1. By Product Type
18.8.2. By Form
18.8.3. By Sales Channel
18.9. Italy Market Analysis
18.9.1. By Product Type
18.9.2. By Form
18.9.3. By Sales Channel
18.10. Spain Market Analysis
18.10.1. By Product Type
18.10.2. By Form
18.10.3. By Sales Channel
18.11. Belgium Market Analysis
18.11.1. By Product Type
18.11.2. By Form
18.11.3. By Sales Channel
18.12. Netherlands Market Analysis
18.12.1. By Product Type
18.12.2. By Form
18.12.3. By Sales Channel
18.13. Nordic Market Analysis
18.13.1. By Product Type
18.13.2. By Form
18.13.3. By Sales Channel
18.14. Russia Market Analysis
18.14.1. By Product Type
18.14.2. By Form
18.14.3. By Sales Channel
18.15. Poland Market Analysis
18.15.1. By Product Type
18.15.2. By Form
18.15.3. By Sales Channel
18.16. China Market Analysis
18.16.1. By Product Type
18.16.2. By Form
18.16.3. By Sales Channel
18.17. Japan Market Analysis
18.17.1. By Product Type
18.17.2. By Form
18.17.3. By Sales Channel
18.18. South Korea Market Analysis
18.18.1. By Product Type
18.18.2. By Form
18.18.3. By Sales Channel
18.19. India Market Analysis
18.19.1. By Product Type
18.19.2. By Form
18.19.3. By Sales Channel
18.20. Thailand Market Analysis
18.20.1. By Product Type
18.20.2. By Form
18.20.3. By Sales Channel
18.21. Malaysia Market Analysis
18.21.1. By Product Type
18.21.2. By Form
18.21.3. By Sales Channel
18.22. Vietnam Market Analysis
18.22.1. By Product Type
18.22.2. By Form
18.22.3. By Sales Channel
18.23. Philippines Market Analysis
18.23.1. By Product Type
18.23.2. By Form
18.23.3. By Sales Channel
18.24. Indonesia Market Analysis
18.24.1. By Product Type
18.24.2. By Form
18.24.3. By Sales Channel
18.25. Singapore Market Analysis
18.25.1. By Product Type
18.25.2. By Form
18.25.3. By Sales Channel
18.26. Australia Market Analysis
18.26.1. By Product Type
18.26.2. By Form
18.26.3. By Sales Channel
18.27. New Zealand Market Analysis
18.27.1. By Product Type
18.27.2. By Form
18.27.3. By Sales Channel
18.28. GCC Countries Market Analysis
18.28.1. By Product Type
18.28.2. By Form
18.28.3. By Sales Channel
18.29. Turkiye Market Analysis
18.29.1. By Product Type
18.29.2. By Form
18.29.3. By Sales Channel
18.30. Egypt Market Analysis
18.30.1. By Form
18.30.2. By Sales Channel
18.31. South Africa Market Analysis
18.31.1. By Product Type
18.31.2. By Form
18.31.3. By Sales Channel
19. Market Structure Analysis
19.1. Global Competition - a Dashboard View
19.2. Industry Structure Analysis
19.2.1. % tier 1 market players
19.2.2. % tier 2 market players
19.2.3. % tier 3 market players
19.3. Global Market Company Share Analysis
19.3.1. For Tier 1 Market Players, 2024
19.3.2. Company Market Share Analysis of Top Players, By Region
19.4. Key Participants Market Presence (Intensity Mapping) by Region
20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competition Deep Dive
20.3.1. NOW Foods
20.3.1.1. Product Portfolio
20.3.1.2. Product Claim
20.3.1.3. Revenue by Market Segments (Product/ channel/Region)
20.3.1.4. Sales Footprint
20.3.1.5. Strategy Overview
20.3.1.5.1. Marketing Strategy
20.3.1.5.2. Product Strategy
20.3.1.5.3. Channel Strategy
20.3.1.6. SWOT Analysis
20.3.2. Nature's Way
20.3.3. Garden of Life
20.3.4. Herbalife Nutrition
20.3.5. Pfizer
20.3.6. Bayer AG
20.3.7. Pharmavite LLC (Nature Made, MegaFood)
20.3.8. Procter & Gamble (New Chapter)
20.3.9. Thorne HealthTech, Inc.
20.3.10. Life Extension
20.3.11. Other Players (On Additional Requests)
21. Assumptions and Acronyms Used
22. Research Methodology
Explore Food and Beverage Insights
View Reports
Menopause Supplement Market
